Rare diseases in India: Are we failing children who could be cured in time? India's cancer battle: Why positivity and early diagnosis are key to higher survival rates World Sickle Cell Day | What India needs to do to eliminate this genetic blood disorder by 2047 Stem cell transplantation: Why India needs more donors OPINION | CAR T-cell therapy is proving to be promising in the treatment of solid tumours It is time to prioritise Sickle Cell Disease care in India How cell and gene therapies revolutionising cancer care in India Rewriting our DNA: The potential of gene editing for blood disorders and beyond Dr Kharya and some heartwarming moments with his patient at the Hospital
Dr. Gaurav Kharya

Rare diseases in India: Are we failing children who could be cured in time?

Date 17-Dec-2025 | By Dr Gaurav Kharya

Despite advances in transplant capacity and policy frameworks, early detection, affordable treatment, and coordinated rare-disease care remain urgent national needs

Dr. Gaurav Kharya

India's cancer battle: Why positivity and early diagnosis are key to higher survival rates

Date 01-Aug-2025 | By Dr Gaurav Kharya

Positivity in cancer treatment, especially for children, is highlighted as a profoundly potent tool that enhances healing and outcomes, going beyond medical protocols

Dr. Gaurav Kharya

World Sickle Cell Day | What India needs to do to eliminate this genetic blood disorder by 2047

Date 20-Jun-2025 | By : Dr Gaurav Kharya

The National Sickle Cell Elimination Mission has made a promising start, but the road to 2047 will require public-private collaboration and consistent efforts to achieve its grand vision

Dr. Gaurav Kharya

Stem cell transplantation: Why India needs more donors

Date 16-Jun-2025 | By : Dr Gaurav Kharya

Every year in India, thousands of children are born with blood disorders like thalassemia major and sickle cell anemia—conditions that condemn them to a life of regular blood transfusions, chronic pain, social stigma, and premature death unless they receive a curative treatment: a stem cell transplant.

Dr. Gaurav Kharya

OPINION | CAR T-cell therapy is proving to be promising in the treatment of solid tumours

Date 21-Sep-2024 | By : Dr Gaurav Kharya

Chimeric Antigen Receptor T-cell (CAR T-cell) therapy has been used and is fast becoming a treatment of choice for patients suffering from blood cancers like leukemia and lymphoma

Dr. Gaurav Kharya

It is time to prioritise Sickle Cell Disease care in India

Date 19-Jun-2024 | By : Dr Gaurav Kharya

Sickle cell disease (SCD) is a severe hereditary blood disorder that poses a significant public health challenge in India, particularly in regions with high malaria rates, known as the "sickle belt," which extends from West Bengal, Orissa, Jharkhand, Madhya Pradesh, Chhattisgarh, and Bihar to Maharashtra and Gujarat.

Dr. Gaurav Kharya

How cell and gene therapies revolutionising cancer care in India

Date 10-Jul-2024 | By : Dr Gaurav Kharya

Our body is made up of cells, and whatever happens to it—good or bad—happens at a cellular level. Cancer, for example, occurs due to a small change in the cell that prompts it to proliferate abnormally. Also, cancer spreads in the body because the immune cells lose their ability to identify the danger cancer cells pose and stop them from growing. We treat cancer by surgically removing the cancer cells from the body or by giving drugs that kill the malignant cells.

Dr. Gaurav Kharya

Rewriting our DNA: The potential of gene editing for blood disorders and beyond

Date 17-Aug-2024 | By : Dr Gaurav Kharya

Gene editing, particularly with CRISPR-Cas9 technology, has shown potential to revolutionise medicine by offering cures for a range of genetic disorders, especially blood disorders such as sickle-cell anaemia.

Dr. Gaurav Kharya

Young and Thriving

Date 03-Feb-2016 | By : Gunjan Sharma

Navdeep Kaur is chirpy, her eyes bright as she watches a movie on her tablet during the last cycle of chemotherapy at BLK Hospital in Delhi. So contagious is her cheerfulness that her grandmother Gurmail Kaur, who is sitting beside her, is hardly nervous.